Article
Circumvention of tamoxifen resistance by the pure anti‐estrogen ICI 182, 780
11 Nov 1993
Abstract excerpt
Both primary and acquired resistance to the growth-inhibitory effects of anti-estrogens (e.g., tamoxifen) limits the clinical usefulness of these drugs in the treatment of breast cancer. The new, steroidal anti-estrogen ICI 182,780 was tested for its ability to inhibit the proliferation of a tamoxifen-resistant variant of the parental MCF-7 human breast-cancer cell line. Two cell lines cloned from the MCF-7 line...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
